- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on mCRC
Total 178 results
-
Peter MacCallum Cancer Centre, AustraliaSuspendedPidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer (REPAIR)Metastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
Istituto Scientifico Romagnolo per lo Studio e...TerminatedMetastatic Castration Resistant Prostate Cancer (mCRPC)Italy
-
Chinese University of Hong KongNot yet recruitingCRC, Colorectal CancerHong Kong
-
AGC Biologics S.p.A.CompletedColorectal Cancer (CRC)Italy
-
Beth Israel Medical CenterCompletedColorectal Cancer (CRC)United States
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)China
-
AstraZenecaCompletedMetastatic Castrate-Resistant Prostate Cancer (mCRPC), | Efficacy, | Safety and Tolerability, | Pharmacokinetics, | Pharmacodynamics, | Tumour Response.United Kingdom, United States
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma (mRCC)Germany
-
University of California, IrvineActive, not recruitingColorectal Cancer | Metastatic Cancer | Colorectal Carcinoma | CRCUnited States
-
National Cancer Institute (NCI)RecruitingColorectal Neoplasms | Colorectal Cancer | Cholangiocarcinoma | Bile Duct Cancer | Bile Duct Neoplasms | Metastatic Colorectal Cancer (Mcrc) | Intrahepatic Cholangiocarcinoma (Icc) | Intrahepatic Bile Duct CancerUnited States
-
Novartis PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)France
-
Incyte CorporationActive, not recruitingBreast Cancer | Pancreatic Cancer | Lung Cancer | Colorectal Cancer (CRC)United States
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma (mRCC)Norway
-
Cardiff OncologyPfizerRecruitingMetastatic Colorectal Cancer | CRC | KRAS/NRAS MutationUnited States
-
Boehringer IngelheimTerminated
-
Chinese University of Hong KongRecruiting
-
Novartis PharmaceuticalsRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)China
-
PfizerAnalysis Group; IMDC groupCompletedMetastatic Renal Cell Carcinoma (mRCC)Canada
-
PfizerCompletedMetastatic Renal Cell Carcinoma (mRCC)Spain, Italy, Belgium, France, United Kingdom, Austria, Greece, Netherlands
-
PfizerCompletedMetastatic Renal Cell Carcinoma ( mRCC)Ecuador, Argentina, Brazil, Colombia
-
Nuvation Bio Inc.RecruitingPancreatic Cancer | Advanced Solid Tumor | HER2-negative Breast Cancer | Metastatic Castration-resistant Prostate Cancer (mCRPC) | Platinum-resistant Ovarian Cancer (PROC)United States
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
PfizerCompletedMetastatic Castration Resistant Prostate Cancer (mCRPC) | Metastatic Castration Sensitive Prostate Cancer (mCSPC)Finland
-
AmgenActive, not recruitingColorectal Cancer (CRC)France, Spain, Korea, Republic of, United States, United Kingdom, Taiwan, Italy, Greece, Australia, Japan, Germany, Mexico
-
ViomeTerminatedColorectal Cancer | Gastrointestinal Cancer | Tumor | CRC | GI CancerUnited States
-
Celcuity IncRecruitingProstate Cancer | Prostatic Neoplasms, Castration-Resistant | Genital Diseases, Male | Prostatic Disease | mCRPC (Metastatic Castration-resistant Prostate Cancer) | Urogenital Diseases, MaleUnited States, France, Spain, United Kingdom
-
Blue Earth Therapeutics LtdPSI CRORecruitingUrogenital Neoplasms | Prostatic Neoplasms | Prostatic Diseases | Prostate Cancer | Metastatic Castration-resistant Prostate Cancer | mCRPCUnited States, Netherlands
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
Jiangsu Simcere Pharmaceutical Co., Ltd.UnknownAdvanced or Metastatic Gastric Cancer | Advanced or Metastatic CRC | Advanced or Metastatic Liver Cancer | Advanced or Metastatic Non Squamous NSCLCChina
-
AbbVieTerminatedGastric Cancer | Colorectal Cancer (CRC)United States
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
Hansoh BioMedical R&D CompanyRecruitingMetastasis Castration Resistant Prostate Cancer(mCRPC)China
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
-
Promontory Therapeutics Inc.Active, not recruitingUrogenital Neoplasms | Neoplasms by Site | Genital Neoplasms, Male | Prostatic Neoplasms | Advanced Solid Tumors | mCRPC | Metastatic Castrate-resistant Prostate Cancer | CRPC | PT-112United States, France
-
C4 Therapeutics, Inc.RecruitingMelanoma | NSCLC | Solid Tumors | CRC | ATCUnited States, Spain, France
-
Universal DiagnosticsRecruitingColorectal Cancer (CRC) | Advanced Adenomas (AA)United States
-
Duke UniversityCompletedMetastatic Renal Cell Carcinoma | Metastatic Urothelial Carcinoma | Metastatic Castration-resistant Prostate Cancer (mCRPC)United States
-
Check-Cap Ltd.CompletedHigh Risk (Above Average) Subjects | Non Compliant Patients for Colo Rectal Cancer [CRC] Screening | Counterindicated Patients for ColonoscopyIsrael
-
Jennerex BiotherapeuticsTransgeneCompletedColorectal Carcinoma | CRCCanada, United States, France
-
PfizerEMD Serono; Astellas Pharma Inc; Nektar TherapeuticsTerminatedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Metastatic Castration Resistant Prostate Cancer (mCRPC)Spain, United States, Poland, Belgium
-
Inspirna, Inc.RecruitingGastrointestinal Neoplasms | Colorectal Neoplasms | Gastric Cancer | Colorectal Cancer | Colorectal Cancer Metastatic | Gastrointestinal Cancer | Colorectal Carcinoma | CRC | KRAS Mutation-Related Tumors | Gastric NeoplasmUnited States
-
Hospital of MacerataRecruiting
-
MedImmune LLCCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC) | Small Cell Lung Cancer (SCLC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Head and Neck Squamous Cell Carcinoma (HNSCC) | Colorectal Cancer (CRC) | Non Small Cell Lung Cancer Squamous (NSCLC-Sq)United States, Canada
-
National Taiwan University HospitalUnknownColorectal Cancer (CRC)Taiwan
-
Guangdong Provincial People's HospitalUnknownColorectal Cancer | Potentially Resectable Liver Metastasis From CRCChina
-
Klinikum FloridsdorfMedical University of Vienna; Klinik Favoriten; Salzkammergut Klinikum VöcklabruckCompletedThe Aim of This Study is to Determine the Influence of BMI and Lymph Node Status on OS in CRC Patients in the Long TermAustria
-
Palleon Pharmaceuticals, Inc.RecruitingMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
Nutricia ResearchRecruitingNon-small Cell Lung Cancer (NSCLC) | Colorectal Cancer (CRC)Ireland
-
IRCCS San RaffaeleUniversità Vita-Salute San RaffaeleRecruitingLiver Metastasis | Pancreatic Ductal Adenocarcinoma (PDAC) | Colorectal Cancer (CRC)Italy
-
Debiopharm International SARecruitingPancreatic Ductal Adenocarcinoma (PDAC) | Colorectal Cancer (CRC) | Clear Cell Renal Cell Cancer (ccRCC)France, Australia